Mvil, LLC
- SEC CIK
- 0001914583
No open-market purchases or sales filed in the past year.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.10% Owneras of Mar 17, 2022
- GRNA GreenLight Biosciences Holdings, PBC10% Owneras of Mar 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mvil, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMLX Amylyx Pharmaceuticals, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 (view filing)5:14 PM ET | Jan 11 | 65 days | Morningside Venture Investments Ltd and 1 other10% Owner | PPurchase | +263.2K | $19.00 | +$5.00M | +2.5%10.7M after | AmendedDuplicate filing |
GRNA GreenLight Biosciences Holdings, PBC
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 (view filing)5:11 PM ET | Feb 2 | 43 days | Morningside Venture Investments Ltd and 1 other10% Owner | PPurchase | +1.00M | – | – | +7.8%13.9M after | Amended |